BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19814830)

  • 1. Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.
    Vallely A; Shagi C; Lees S; Shapiro K; Masanja J; Nikolau L; Kazimoto J; Soteli S; Moffat C; Changalucha J; McCormack S; Hayes RJ
    BMC Med Ethics; 2009 Oct; 10():17. PubMed ID: 19814830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa.
    Shagi C; Vallely A; Kasindi S; Chiduo B; Desmond N; Soteli S; Kavit N; Vallely L; Lees S; Hayes R; Ross D;
    AIDS Care; 2008 Oct; 20(9):1039-49. PubMed ID: 18825513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania.
    Vallely A; Shagi C; Kasindi S; Desmond N; Lees S; Chiduo B; Hayes R; Allen C; Ross D;
    BMC Public Health; 2007 Jul; 7():133. PubMed ID: 17697333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.
    Vallely A; Lees S; Shagi C; Kasindi S; Soteli S; Kavit N; Vallely L; McCormack S; Pool R; Hayes RJ;
    BMC Med Ethics; 2010 Jun; 11():10. PubMed ID: 20540803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?
    Vallely A; Hambleton IR; Kasindi S; Knight L; Francis SC; Chirwa T; Everett D; Shagi C; Cook C; Barberousse C; Watson-Jones D; Changalucha J; Ross D; Hayes RJ;
    PLoS One; 2010 May; 5(5):e10661. PubMed ID: 20498833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal and menstrual practices among women working in food and recreational facilities in Mwanza, Tanzania: implications for microbicide trials.
    Allen CF; Desmond N; Chiduo B; Medard L; Lees SS; Vallely A; Francis SC; Ross DA; Hayes RJ
    AIDS Behav; 2010 Oct; 14(5):1169-81. PubMed ID: 20665101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials.
    Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
    PLoS One; 2021; 16(1):e0244652. PubMed ID: 33411782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
    Obiero J; Mwethera PG; Hussey GD; Wiysonge CS
    BMC Infect Dis; 2012 Nov; 12():289. PubMed ID: 23130761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community and research staff collaboration for development of materials to inform microbicide study participants in Africa.
    Woodsong C; Mutsambi JM; Ntshele S; Modikoe P
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19156. PubMed ID: 25224615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supporting young women's health through girl-friendly drug vendors in Lake Zone, Tanzania: protocol for the AmbassADDOrs for Health cluster-randomised controlled trial.
    Mnyippembe A; Sheira LA; McCoy SI; Njau PF; Packel LJ; Hassan K; Solorzano-Barrera C; Maokola W; Kang Dufour MS; Sabasaba A; Liu J
    BMJ Open; 2024 Jun; 14(6):e078755. PubMed ID: 38851225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
    BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J; Mwethera PG; Wiysonge CS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
    AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twice-daily application of HIV microbicides alter the vaginal microbiota.
    Ravel J; Gajer P; Fu L; Mauck CK; Koenig SS; Sakamoto J; Motsinger-Reif AA; Doncel GF; Zeichner SL
    mBio; 2012 Dec; 3(6):. PubMed ID: 23249810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.